{
    "clinical_study": {
        "@rank": "158065", 
        "acronym": "WF", 
        "arm_group": [
            {
                "arm_group_label": "Arm 1: Preconception", 
                "arm_group_type": "Experimental", 
                "description": "Arm 1 will commence the comprehensive maternal nutrition intervention at 7 months postpartum. Delivery of the intervention will be monitored biweekly by collection of empty and unused sachets of the lipid-based supplement (LNS), maternal report, and casual observation of household behavior. Arm 1 participants will be weighed monthly and BMI calculated. If BMI <19 an additional supplement will be provided. Menstrual history will be obtained at each visit and a urine pregnancy test will be performed if menses is delayed."
            }, 
            {
                "arm_group_label": "Arm 2: Pregnancy", 
                "arm_group_type": "Experimental", 
                "description": "Participants in Arm 2 will commence the comprehensive maternal nutrition intervention at 12 weeks gestation."
            }, 
            {
                "arm_group_label": "Arm 3: Control", 
                "arm_group_type": "No Intervention", 
                "description": "Participants in Arm 3 will receive biweekly visits to monitor pregnancy status. No health advice will be given other than information about prenatal care, location of delivery, and breastfeeding education in the third trimester."
            }
        ], 
        "brief_summary": {
            "textblock": "Multi-country three-arm, individually randomized, non-masked, controlled trial to ascertain\n      the benefits of ensuring optimal maternal nutrition before conception and providing an\n      evidence base for programmatic priority directed to minimizing the risk of malnutrition in\n      all females of reproductive age."
        }, 
        "brief_title": "Women First: Preconception Maternal Nutrition", 
        "completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Maternal Malnutrition", 
            "Growth Failure", 
            "Mortality", 
            "Morbidity", 
            "Stunting"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Failure to Thrive", 
                "Malnutrition"
            ]
        }, 
        "detailed_description": {
            "textblock": "The objective is to determine the benefits to the offspring of women in poor, food-insecure\n      environments of commencing a daily comprehensive maternal nutrition supplement (with\n      additional balanced calorie/protein supplement for underweight participants) \u2265 3 months\n      prior to conception versus the benefits of commencing the same supplement at 12 weeks\n      gestation and also to compare offspring outcomes with those of a control group which\n      receives no supplement."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  16-35 years of age;\n\n          -  0-3 children;\n\n          -  expectation to have first or further pregnancy without intent to utilize\n             contraception\n\n          -  Hb >8 g/dL\n\n        Exclusion Criteria:\n\n        - Nulliparous women who do not agree to hospital delivery (equipped for caesarian section)\n        or/and do not have ready access to such a facility."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "5760", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01883193", 
            "org_study_id": "12-1672", 
            "secondary_id": [
                "OPP1055867", 
                "U10HD076474-01"
            ]
        }, 
        "intervention": {
            "arm_group_label": [
                "Arm 1: Preconception", 
                "Arm 2: Pregnancy"
            ], 
            "description": "The nutrition intervention will be delivered before conception or at 12 weeks gestation and compared with a control group.  The supplement to be used is a multi-micronutrient (MMN) fortified lipid-based supplement composed of dried skimmed milk, soybean and peanut extract, sugar, maltodextrin stabilizers, and emulsifiers.", 
            "intervention_name": "Comprehensive Maternal Nutrition Intervention", 
            "intervention_type": "Dietary Supplement", 
            "other_name": [
                "multi micronutrient (MMN) fortified lipid-based supplement", 
                "lipid-based nutrient supplement", 
                "LNS"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Micronutrients", 
                "Trace Elements"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "preconception maternal nutrition", 
            "LBW", 
            "Length-for-age", 
            "maternal nutrition supplement", 
            "multi-micronutrient fortified lipid-based supplement", 
            "infant growth", 
            "low-resource settings"
        ], 
        "lastchanged_date": "March 25, 2014", 
        "location": [
            {
                "contact": {
                    "email": "antoshe@yahoo.com", 
                    "last_name": "Antoinette Tshefu, MD", 
                    "phone": "243 810 156 910"
                }, 
                "contact_backup": {
                    "last_name": "Carl Bose, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Kinshasa", 
                        "country": "Congo, The Democratic Republic of the"
                    }, 
                    "name": "Kinshasa School of Public Health"
                }, 
                "investigator": {
                    "last_name": "Antoinette Tshefu, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "anagarces@imsalud.org", 
                    "last_name": "Ana Garc\u00e9s, MD, MPH", 
                    "phone": "502 2332-4064"
                }, 
                "contact_backup": {
                    "email": "lesterfigueroa@me.com", 
                    "last_name": "Lester Figueroa, MD", 
                    "phone": "502 5555-2325"
                }, 
                "facility": {
                    "address": {
                        "city": "Guatemala City", 
                        "country": "Guatemala"
                    }, 
                    "name": "FANCAP / San Carlos University"
                }, 
                "investigator": {
                    "last_name": "Ana Garces, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sgoudar@jnmc.edu", 
                    "last_name": "Shivaprasad S. Goudar, MD, MHPE", 
                    "phone": "91 831 244 4194"
                }, 
                "contact_backup": {
                    "email": "drdhadedsm@gmail.com", 
                    "last_name": "Sangappa Dhaded, MD", 
                    "phone": "91 831 247 1465"
                }, 
                "facility": {
                    "address": {
                        "city": "Belgaum", 
                        "country": "India", 
                        "zip": "590 010"
                    }, 
                    "name": "Jawaharlal Nehru Medical College"
                }, 
                "investigator": {
                    "last_name": "Shivaprasad S. Goudar, MD, MHPE", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "omrana.pasha@aku.edu", 
                    "last_name": "Omrana Pasha, MD", 
                    "phone": "92-21-486 4948"
                }, 
                "contact_backup": {
                    "email": "sumera.ali@aku.edu", 
                    "last_name": "Sumera Ali", 
                    "phone": "92-33 2-355-0437"
                }, 
                "facility": {
                    "address": {
                        "city": "Karachi", 
                        "country": "Pakistan"
                    }, 
                    "name": "Aga Khan University"
                }, 
                "investigator": {
                    "last_name": "Omrana Pasha, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Congo, The Democratic Republic of the", 
                "Guatemala", 
                "India", 
                "Pakistan"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "Women First: Preconception Maternal Nutrition", 
        "overall_contact": {
            "email": "Michael.Hambidge@ucdenver.edu", 
            "last_name": "Michael Hambidge, MD, ScD", 
            "phone": "303.724.3261"
        }, 
        "overall_contact_backup": {
            "email": "Nancy.Krebs@ucdenver.edu", 
            "last_name": "Nancy Krebs, MD, MS", 
            "phone": "303-724-3260"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Colorado, Denver", 
                "last_name": "Michael Hambidge, MD, ScD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Colorado, Denver", 
                "last_name": "Nancy Krebs, MD, MS", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Research assistants will obtain neonatal length measurement at 2 days of age.", 
            "measure": "Neonatal linear growth", 
            "safety_issue": "No", 
            "time_frame": "48 hours of age"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01883193"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Research assistants will obtain infant anthropometry measurements, which include length, head circumference, triceps skin folds, Mid Upper Arm Circumference (MUAC), and weight, at age 0.5, 1, 3, and 6 months of age.  Length-for-age Z-scores will be compared for offspring of mothers randomized to the three intervention arms.", 
                "measure": "Length-for-age Z-scores", 
                "safety_issue": "No", 
                "time_frame": "age 0.5, 1, 3 and 6 months postnatal"
            }, 
            {
                "description": "Ultrasound measurements will be undertaken at 12 weeks gestation with the goals of confirming gestational age and estimating fetal growth.", 
                "measure": "Estimate fetal growth", 
                "safety_issue": "No", 
                "time_frame": "12 weeks gestation"
            }, 
            {
                "description": "As a dichotomous variable, the cutoff of 2500 g does not have the power of the continuum of birth length, but is included because of the long history of use in determining which newborns are severely underweight and this association with impaired neonatal and long-term prognosis.  The design of this study will allow distinction between pre-term birth (PTB) and growth retardation of the term infant (mature IUGR).", 
                "measure": "Mean birth weight and incidence of low birth weight (LBW) infants", 
                "safety_issue": "No", 
                "time_frame": "at birth"
            }, 
            {
                "description": "The outcome is to determine, in poor food insecure communities if a daily comprehensive maternal nutrition supplement starting \u2265 3 months preconception and continuing throughout pregnancy will reduce the incidence of offspring perinatal mortality (including still births), compared with that for offspring of mothers who commence the same supplement starting at 12-16 weeks gestation.", 
                "measure": "Perinatal Mortality", 
                "safety_issue": "No", 
                "time_frame": "after 20 weeks gestation up to 1 months of age"
            }, 
            {
                "description": "Outcome measure is number of acute visits / admissions to health center/hospital for severe infectious disease.  This secondary outcome will provide insight into the importance of maternal and fetal nutrition in the early prenatal development of host-defense mechanisms and, through comparison with the prenatal and control Arms, on the importance of maternal nutrition throughout pregnancy. It is further intended to collect minor morbidity data.", 
                "measure": "Incidence of severe neonatal and infant infectious disease", 
                "safety_issue": "No", 
                "time_frame": "birth to 6 months of age"
            }, 
            {
                "description": "To compare longitudinal changes between groups in the maternal epigenome (including blood, buccal swabs, and possibly other readily obtainable samples) at baseline, 12 weeks pregnancy (prior to initiation of LNS in Arm 2), 30 weeks pregnancy, and at 3 months postpartum. Also will collect placental, fetal and cord blood epigenome at delivery by group and infant epigenome at 3 months with fingerstick blood.", 
                "measure": "Epigenome (Maternal and Infant)", 
                "safety_issue": "No", 
                "time_frame": "baseline, 12 weeks and 30 weeks gestation, delivery, and 3 months postpartum (maternal); delivery and 3 months of age (infant)"
            }, 
            {
                "description": "These investigations will address in detail group differences in Zn homeostasis reflecting longer-term Zn status (by exchangeable Zn pool (EZP) size) as well as absorption of current intake of bioavailable Zn, including Zn absorption from LNS and (separately) from remainder of diet. Comparisons will be made between Arm 1 and 2 only with 20 maternal participants per arm, per site.", 
                "measure": "Changes in zinc (Zn) homeostasis", 
                "safety_issue": "No", 
                "time_frame": "12 weeks gestation"
            }, 
            {
                "description": "The outcome represents deep phenotyping by measuring in maternal tissues: hormones, metabolites, measures of inflammation, oxidant stress and immune function/status, and nutrient biomarkers as possible indices of fundamental metabolic alterations resulting from improved long-term maternal nutrition in food insecure populations. Longitudinal blood samples will be collected from maternal participants in Arms 1 and 2 at 12 weeks gestation (prior to initiation of LNS in Arm 2), 30 weeks gestation, delivery and 3 months postpartum and from infants at 14 weeks.", 
                "measure": "Deep phenotyping of maternal metabolic and nutritional status", 
                "safety_issue": "No", 
                "time_frame": "12 and 30 weeks gestation, delivery and at 3 months postpartum (mother) and 14 days of age (infant)"
            }, 
            {
                "description": "Based on potential long-term effects on maternal nutritional and metabolic state from preconception intervention, we hypothesize that the gut microbiota will differ between the two intervention arms at the three proposed time points. Will obtain samples from women in Arm 1 and Arm 2 at each site but will immediately analyze samples from 50 women per arm.", 
                "measure": "Microbiome", 
                "safety_issue": "No", 
                "time_frame": "12 & 30 weeks gestation and delivery (<48 hours) and 14 days of age for the infant"
            }, 
            {
                "description": "We hypothesize that improved maternal nutrition at the time of greatest plasticity in early pregnancy will favorably influence maternal metabolic and nutritional status throughout pregnancy and thus potentially the composition of breast milk in terms of hormonal content, immune factors, cytokines, and gut growth factors.", 
                "measure": "Composition of breast milk", 
                "safety_issue": "No", 
                "time_frame": "14 days postpartum"
            }
        ], 
        "source": "University of Colorado, Denver", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "University of San Carlos", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kinshasa School of Public Health", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Jawaharlal Nehru Medical College", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Aga Khan University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "RTI International", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Colorado, Denver", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}